4% citrate (anti-clotting effect) and 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE)
Catheter lock solution with double effectiveness
TauroLock™ is a preventive lock solution suitable for central venous access within hemodialysis and oncology. In order to ensure a catheter with an optimum blood flow, it is important that the lock solution ensures both clotting and infection prevention. Taurolock’s double effectiveness prevents catheter infections and clot formation.
The double effectiveness of TauroLock Classic consists of the combination of:
Description: 4% citrate (anti-clotting effect) and 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE)
Appearance: Glass ampoule of 3, 5 and 10 mL
Package size: 10 items (3 and 5 mL) and 100 items (10 mL)
Manufacturer: Tauropharm
Receive the available brochures and/or papers
Cablon Medical has developed a lead apron configurator that allows you to put together your own lead apron.